Link to this page

Your search term(s) "statistics" returned 36 results.

Page 1 2 3 4    Display All

2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse. 2008. (CD-ROM)

This CD-ROM contains PDF files of the entire Annual Data Report (ADR) of the United States Renal Data System (USRDS), reporting data from 2008. The disk contains PowerPoint slides of the atlas figures and tables, Excel files of all data, and supplemental reference tables. Volume 1 of the ADR offers five chapters beginning with a summary of chronic kidney disease (CKD), CKD in the National Health and Nutrition Examination Survey (NHANES) populations, CKD identified in the claims data, morbidity and mortality, the transition to end-stage renal disease (ESRD), and the costs of chronic kidney disease. Volume 2 is the atlas itself, beginning with a detailed summary and then offering 13 chapters covering the Healthy People 2010 project, emerging issues, incidence and prevalence of ESRD, patient characteristics, treatment modalities, clinical indicators and preventive health, morbidity and mortality, transplantation, pediatric ESRD, special studies, ESRD providers, the costs of ESRD, and international comparisons. The data is illustrated with full-color charts, tables, and graphics. Volume 3 presents the frequently requested data in the reference tables as appendices. Thirteen chapters cover incidence, prevalence, patient characteristics, treatment modalities, the process and outcomes of transplantation, morbidity and hospitalization, mortality and causes of death, patient survival, provider characteristics, the economic costs of ESRD, vascular access, and census populations. Each chapter presents at least half of the data in chart, table, or diagram format. A glossary of terms and a detailed subject index are included.

Full Record   Printer Friendly Version

Concise 2008 Annual Data Report of Atlas of Chronic Kidney Disease And End-Stage Renal Disease in the United States. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse. 31 p.

This small booklet presents a summarized version of the Annual Data Report (ADR) of the United States Renal Data System (USRDS), reporting data from 2008. The booklet presents a few charts and figures of data, covering chronic kidney disease (CKD) and end-stage renal disease (ESRD) patient populations, CKD prevalence, CKD patient comorbidity, hospitalization in CKD patients, diagnosis and treatment of CKD patients with cardiovascular disease, mortality in CKD patients, costs of CKD, costs during the transition to ESRD, the transition to ESRD, ESRD incidence and prevalence, geographic variations in rates of ESRD, transplantation in ESRF patients, clinical care, hospitalization, mortality, survival, and costs of ESRD. One section describes the products and services available through the USRDS.

Full Record   Printer Friendly Version

CROWNWeb: The Evolution of Kidney Data Management (Part I). Nephrology News & Issues. 22(3): 42-46. March 2008.

This article describes a web-based application called Consolidated Renal Operations in a Web-Enabled Network (CROWNWeb), developed by the U.S. Centers for Medicare and Medicaid Services. CROWNWeb is designed to support and improve data entry, updating, and retrieval for use by dialysis facilities nationwide. CROWNWeb will provide more timely data to facilities and improve data accessibility, eliminate collection redundancy, and strengthen community collaboration. In this article, part one of a three-part series, the author reviews the history of end-stage renal disease (ESRD) and Medicare and discusses the rapid growth of ESRD data management as well as other events that require progression to an online data collection and management system. The author describes the three software programs that serve as the foundation of CROWNWeb: SIMS, which is the patient and facility registry for dialysis and transplant facilities; VISION, which afforded independent dialysis facilities the ability to submit forms, patient tracking data, and maintain their patient registry to the ESRD networks electronically; and REMIS, which provided a means to determine Medicare coverage periods for ESRD patients and to store and access information in the database. The article concludes with a description of the move from a computer-based desktop system onto the web, discussing data accessibility, comparative data, security, and cost-effectiveness. 1 figure. 5 references.

Full Record   Printer Friendly Version

Hospitalization Discharge Diagnoses for Kidney Disease - United States, 1980-2005. Morbidity and Mortality Weekly Report. 57(12): 309-312. March 2008.

This report from the Centers for Disease Control and Prevention (CDC) provides information about hospitalization discharge diagnoses for kidney disease in the United States from 1980 to 2005. The CDC analyzed data from the National Hospital Discharge Survey for this period. The results of that analysis are presented in this article. The authors note that the numbers and rates of kidney disease hospital discharge diagnoses have increased since the early 1990s, especially among adults older than 65 years. A shift has occurred in the type of kidney disease accounting for most of these reported hospitalizations, shifting from chronic kidney failure (CKD) to acute renal failure (ARF). An increasing number of kidney disease hospital discharges are associated with a concomitant diagnosis of diabetes mellitus of hypertension. An editorial note appended to the article considers whether the cause of the increase in hospitalizations with ARF diagnoses is showing an actual increase in ARF or to changes in the way ARF is diagnosed, defined, or reflected in hospital discharge codes. The authors call for additional research to determine the cause of the increase in ARF discharge diagnoses and to quantify the progression from ARF to CKD and end-stage renal disease (ESRD). 2 figures. 1 table. 9 references.

Full Record   Printer Friendly Version

Kidney and Urologic Diseases Statistics for the United States. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse. 2008. 6 p.

This fact sheet summarizes statistics from the United States on patients with kidney and urologic diseases. Categories covered including the prevalence of kidney disease; the incidence of postdiarrheal hemolytic uremic syndrome (HUS); the prevalence, incidence, mortality, costs, treatment, number of transplants performed, source of organ donations, number of people awaiting transplants, dialysis survival, patient survival posttransplantation, and graft survival of end-stage renal disease (ESRD); the prevalence of interstitial cystitis (IC); the prevalence, hospital stays, physician office visits, and costs of urinary stones; the prevalence, inpatient hospital stays, physician office visits, and costs of urinary tract infections (UTIs); the prevalence, inpatient hospital stays, physician office visits, and costs of urinary incontinence; the prevalence, doctor visits, and costs for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS); the prevalence of erectile dysfunction (ED); and the incidence and costs of prostate cancer. The information is presented in a bulleted format, with minimal text. The sources of the information are listed in the reference list. The fact sheet concludes with a brief description of the goals and activities of the National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC). 21 references.

Full Record   Printer Friendly Version

USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease in the United States. Volume 1. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse. 2008. 110 p.

This manual is volume 1 of the Annual Data Report (ADR) of the United States Renal Data System (USRDS), reporting data from 2008. Volume I offers five chapters beginning with a summary of chronic kidney disease (CKD), then covering CKD in the National Health and Nutrition Examination Survey (NHANES) populations, CKD identified in the claims data, morbidity and mortality, the transition to end-stage renal disease (ESRD), and the costs of chronic kidney disease. Chapter 1 covers prevalence estimates, the type and degree of biochemical abnormalities present in CKD, the prevalence of CKD in association with other comorbid conditions such as diabetes and cardiovascular disease, risk factors for CKD, and data showing that management of risk factors such as hypertension and cardiovascular disease in CKD patients is characterized by poor control of blood pressure and lipid levels. Chapter 2 addresses CKD in the Medicare and employer group health plan (EGHP) data. Chapter 3 presents data on morbidity and mortality, demonstrating the high rates of hospitalization in CKD compared with non-CKD patients. Chapter 4 begins with information about patients who advance from CKD to ESRD, as well as those who will die as a result of their CKD, and then discusses the importance of early diagnosis of CKD and the identification and amelioration of risk factors for the condition. The final chapter offers information about costs associated with the CKD population, including both the Medicare and EGHP systems. Each chapter presents at least half of the data in full-color chart, table, or diagram format. Appendices describe in detail the analytical methods used to create the data tables.

Full Record   Printer Friendly Version

USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Volume 2. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse. 262 p.

This manual is volume 2 of the Annual Data Report (ADR) of the United States Renal Data System (USRDS), reporting data from 2008. Volume 2 is the atlas itself, beginning with a detailed summary and then offering 12 chapters covering the Healthy People 2010 project, emerging issues, incidence and prevalence of end-stage renal disease (ESRD), patient characteristics, treatment modalities, clinical indicators and preventive health, morbidity and mortality, transplantation, pediatric ESRD, special studies, ESRD providers, the costs of ESRD, and international comparisons. Chapter 1 addresses cause-specific death and hospitalization rates, and illustrates their considerable impact in the first 3 months of hemodialysis. Incident and prevalent counts are reported in Chapter 2, along with projected counts to 2020. Chapter 3 presents information from added data fields on the newly revised medical evidence form, which was introduced in the spring of 2005. Chapter 4 presents information about trends in modality use, including peritoneal dialysis and home hemodialysis. Chapter 5 covers clinical indicators of care, dialysis adequacy, vascular access, anemia treatment, hemoglobin levels, transfusion rates, and preventive care. Chapter 6 offers mortality data, including the use of hospice care in the ESRD population, withdrawal from dialysis, and the burden of walking disability. Chapter 7 presents statistics on the rising numbers of transplantations, waiting times, patterns of immunosuppressive drug use, and cardiovascular disease and death in patients with functioning allografts. The data on pediatric patients provided in Chapter 8 shows a lack of progress in the survival of these patients. In Chapter 9, each Special Studies Center addresses aspects of care related to its target areas. Chapter 10 provides data on the duration of ownership among both the consolidated and remaining dialysis providers, information about iron dosing practices and transfusion use, and data on regional comparisons of large and small dialysis organizations as well as those that are hospital-based. Chapter 11 outlines expenditures related to ESRD, beginning with data on the overall costs of both the Medicare ESRD and employer group health plans (EGHP), and data on the costs incurred during the transition from CKD to ESRD. Chapter 12 summarizes data from the international community, including differences in incidence, prevalence, diabetes-related ESRD, dialysis, and transplantation. Each chapter presents most of the data in full-color chart, table, or diagram format. This volume concludes with a glossary of terms and a detailed subject index.

Full Record   Printer Friendly Version

USRDS 2008 Annual Data Report: Reference Tables on End-Stage Renal Disease in the United States. Volume 3. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse. 350 p.

This manual is volume 3 of the Annual Data Report (ADR) of the United States Renal Data System (USRDS), reporting data from 2008. Volume 3 presents the frequently requested data in the reference tables as appendices. Thirteen chapters cover incidence, prevalence, patient characteristics, treatment modalities, the process and outcomes of transplantation, morbidity and hospitalization, mortality and causes of death, patient survival, provider characteristics, the economic costs of ESRD, vascular access, and census populations. All of the information is presented in charts and tables.

Full Record   Printer Friendly Version

2005 CPMs Regarding Vascular Access Create Opportunities for Improving Care. Nephrology News & Issues. 21(12): 34-35. November 2007.

This article discusses the information from the 2005 Clinical Performance Measures (CPM) Project on vascular access. Vascular access is one of the clinical indicators reviewed each year as part of the CPM Project, which is produced by the End-Stage Renal Disease Networks. The sample for 2005 included about 9,000 randomly selected, in-center, hemodialysis patients who dialyzed during the last quarter of that calendar year. Data from 803 pediatric patients from that same time period are included. The three CPMs for vascular access measured the number of new patients dialyzing with an arteriovenous fistula (AVF), the number of continuing patients dialyzing with an AVF, the percentage of continuing patients dialyzing with a catheter continuously for 90 days or longer, and the percentage of patients whose grafts were routinely monitored for stenosis. In 2005, the data showed that 54 percent of new patients and 44 percent of continuing patients were dialyzed using an AVF, up from 27 percent and 30 percent, respectively, in 2000. The author notes that this is the extent of the positive news from the 2005 report. For example, catheter usage, known to be a major cause of morbidity, mortality, and increased end-stage renal disease (ESRD) expenditure, has not been reduced. Nearly three-quarters of all patients beginning hemodialysis in 2005 did so via a catheter, some 38 percent of these patients with catheters had no surgical access created or planned, and 65 percent of those patients preferred not to have surgery for access. The author reviews the data, discussing CPM goals, monitoring patients for stenosis, the situation with pediatric patients, and strategies to increase the use of AVF for vascular access for hemodialysis. Readers are referred to the complete 2005 Clinical Performance Measures Report, available at www.cms.hhs.gov/CPMProject. 1 reference.

Full Record   Printer Friendly Version

2007 Annual Data Report: Atlas of Chronic Kidney Disease And End-Stage Renal Disease in the United States. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse. 2007. (CD-ROM)

This CD-ROM contains PDF files of the entire Annual Data Report (ADR) of the United States Renal Data System (USRDS), reporting data from 2007. The disk contains PowerPoint slides of the atlas figures and tables, Excel files of all data, and supplemental reference tables. Volume I of the ADR offers 13 chapters covering chronic kidney disease, incidence and prevalence of end-stage renal disease (ESRD), patient characteristics, treatment modalities, clinical indicators and preventive health, morbidity and mortality, transplantation, pediatric ESRD, cardiovascular special studies, ESRD, the costs of CKD and ESRD, and international comparisons. Volume II presents the frequently requested data in the reference tables as appendices. Twelve chapters cover incidence, prevalence, patient characteristics, treatment modalities, the process and outcomes of transplantation, morbidity and hospitalization, mortality and causes of death, patient survival, provider characteristics, the economic costs of ESRD, and vascular access. Each chapter presents at least half of the data in chart, table, or diagram format for ease of access. A glossary of terms and a detailed subject index are included.

Full Record   Printer Friendly Version

Page 1 2 3 4    Display All

Start a new search.